Vertex Pharmaceuticals
VRTX
#154
Rank
C$193.75 B
Marketcap
C$764.21
Share price
-1.07%
Change (1 day)
29.29%
Change (1 year)

EPS for Vertex Pharmaceuticals (VRTX)

EPS in 2023 (TTM): C$17.71

According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$24.47. In 2022 the company made an earnings per share (EPS) of C$18.33 an increase over its 2021 EPS that were of C$12.85.

EPS history for Vertex Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C$17.71-3.37%
2022C$18.3342.64%
2021C$12.85-12.67%
2020C$14.71128.01%
2019C$6.45-44.54%
2018C$11.63670.09%
2017C$1.51-327.66%
2016C-$0.66-79.65%
2015C-$3.26-26.43%
2014C-$4.4353.92%
2013C-$2.88316.33%
2012C-$0.69-545.45%
2011C$0.16-102.92%
2010C-$5.321.34%
2009C-$5.2513.41%
2008C-$4.638.61%
2007C-$4.2664.13%
2006C-$2.60-18.22%
2005C-$3.186.13%
2004C-$2.99-16.86%
2003C-$3.6078.32%
2002C-$2.02164.81%
2001C-$0.76-21.32%
2000C-$0.97-14.21%
1999C-$1.1321.21%
1998C-$0.9357.14%
1997C-$0.59-61.82%
1996C-$1.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.44-61.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$5.04-79.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C-$4.38-117.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.40-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.38-73.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
C-$3.40-113.91%๐Ÿ‡บ๐Ÿ‡ธ USA